Development of a visual scoring method to determine inflamed, excluded or desert immune phenotype in Non-Small Cell Lung Cancer, Colorectal Cancer, and Urothelial Cancer

Home > Science Hub > Development of a visual scoring method to determine inflamed, excluded or desert immune phenotype in Non-Small Cell Lung Cancer, Colorectal Cancer, and Urothelial Cancer
Back to the list

November 7, 2024

Elizabeth Ross

Development of a visual scoring method to determine inflamed, excluded or desert immune phenotype in Non-Small Cell Lung Cancer, Colorectal Cancer, and Urothelial Cancer

You might also be interested by

Brochures & Infographics

Immunohistochemistry (IHC) Biomarker List

October 10, 2024

Histopathology

More info

CellTalk Blog

Optimal FFPE Tissue Fixation, Processing, and Embedding: A Comprehensive Guide

September 4, 2024

Histopathology

More info

CellTalk Blog

Optimizing your in situ hybridization for success

August 30, 2024

Histopathology

More info

Scientific Publications

Fibroblast Activation Protein-a and the Immune Landscape: Unraveling T1 Non–muscle-invasive Bladder Cancer Progression

August 5, 2024

Histopathology

More info